Neutral impactStocks
Exclusive | How Vijay Kedia turned a Rs 250 Neuland Labs bet into nearly 100x returns
Economic Times 1 hr ago·7 Sept 2026, 4:01 am
Investor Vijay Kedia's savvy investment in Neuland Laboratories has paid off handsomely, yielding nearly 100x returns. He seized the opportunity during the Covid downturn when stock prices dipped. By concentrating on the company’s promising peptide sector and its CDMO capabilities, Kedia emphasized his tactic of investing in overlooked firms with solid fundamentals, which has ultimately fostered substantial wealth growth over the years.
Affected stocks
Neutral1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Neuland Laboratories (NEULANDLAB).
- Category: Stocks.
Why it matters
A routine update for Neuland Laboratories. Use the price and stock snapshot to gauge how the market is responding.
